The 6.6 Duramax is one of the most powerful engines for heavy-duty trucks like the Chevy Silverado and GMC Sierra, but how ...

GMC Canyon won top place as the Midsize Pickup that will keep most MSRP after four years per the 2025 J.D. Power 2025 Canada ALG Residual Value Awards.

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

Engine, Vortec 6.0L Variable Valve Timing V8 SFI E85-compatible, FlexFuel capable of running on unleaded or up to 85% ethanol (360 hp [268.4 kW] @ 5400 rpm, 380 lb-ft of torque [515.0 N-m] @ 4200 ...

You can't understand the true ridiculousness of the GMC Hummer EV, without first revisiting a little history of the Hummer brand. The "original" civilian Hummer from the 1990s, also called the H1 ...

The refreshed 2025 GMC Yukon got its big debut last August, bringing with it a variety of updates and changes. One of the most important of these was a revamped trim level hierarchy, including the ...

The GMC Sierra Denali arrived near the start of Y2K, and with it came a game-changing notion: what if hard-working capability could be opulent? This notion has since influenced many of the models ...

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.

A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...

Tenvie Therapeutics has launched with $200 million and a clutch of assets from Denali Therapeutics to go after neurological diseases with small molecules. Backed by ARCH Venture Partners, F-Prime ...

Denali Therapeutics has announced topline results from the phase 2/3 Healey ALS Platform Trial, which evaluated the effects of its drug candidate DNL343. The study did not meet the primary efficacy ...